The Trump administration's recent travel and visa restrictions are preventing medical residents from starting their jobs in the US.

The denosumab biosimilars Stoboclo (denosumab-bmwo) and Osenvelt (denosumab-bmwo) are now available in the US.

The NIH is planning to limit how much publishers can charge NIH-supported scientists to make their research findings publicly available.

Chemotherapy can increase mutation burden and change the cell population structure of normal blood, which contributes to long-term adverse effects such as second malignancies and infertility, ...

The lawsuit was prompted by steps the HHS has taken to “mislead, confuse, and gradually desensitize the public to anti-vaccine and anti-science rhetoric,” according to the plaintiffs.

We report, for the first time to the best of our knowledge, the largest cohort of serial hs-TnI surveillance in patients diagnosed with cancer and treated with ICIs therapies,” the researchers wrote.

This article was originally published on Stateline. The giant tax and spending bill President Donald Trump signed into law over the weekend includes the biggest health care spending cuts in U.S.

The annual growth in national health spending is expected to be higher than average gross domestic product growth in the US during 2024-2033.

The composition of the gut microbiome appears to be associated with treatment response in patients with pancreatic cancer, research suggests.

The US Food and Drug Administration (FDA) has granted accelerated approval to Zegfrovy (sunvozertinib) for the treatment of adults with locally advanced or metastatic non-small cell lung cancer (NSCLC ...

The FDA approved Lynozyfic (linvoseltamab-gcpt) to treat adults with relapsed/refractory multiple myeloma who have received at least 4 prior lines of therapy.

Ashwin Kishtagari, MD, of Vanderbilt University Medical Center in Nashville, summarizes 7 studies presented at the EHA 2025 Congress.